A protease-inhibitor reference used with other antiretrovirals for HIV; confirm current availability and preferred treatment.
Profile scope: Indinavir reference. Confirm the exact product and route; formulations and combination products are not interchangeable.
Possible side effects
Taste changes may occur.
Serious risks and warning signs
Kidney stones or other urinary problems, liver symptoms, blood-cell complications, and serious skin reactions need assessment. Flank pain, blood in urine, jaundice, severe weakness, or blistering warrants prompt advice. Hydration and extensive interaction precautions must be individualized.
A question for your healthcare team
Is this regimen still appropriate, and what kidney, hydration, liver, and interaction plan applies?
What to do with this information
Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.
Sources
Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.